an experimental experience

5/30/23 at 12:46pm

Organization

Author

28 words

Comments

Valneva has submitted a regulatory application to Health Canada, seeking marketing approval for its chikungunya vaccine candidate, VLA1553.

You are the first to view

http://www.pharmaceutical-technology.com/news/valneva-health-canada-chikungunya-vaccine/

Create an account or login to join the discussion